Maggie Chang

EVP, Quality Affairs at Handa Pharmaceuticals

Dr. Chang has over 20 years of experience in quality assurance and quality control, Good Laboratory Practices and Good Manufacturing Practices compliance and oversight, analytical methods development, regulatory submissions, and management of clinical production and testing.

Prior to joining Handa, Dr. Chang served as Vice President of Quality Affairs at Anchen Pharmaceuticals. While at Anchen, she worked on numerous development projects which resulted in ANDA regulatory submissions, including the company’s first ANDA, which received FDA approval in November 2005.

From 1996 to 2002, Dr. Chang held various management positions in the R&D Analytical Department at Impax Laboratories. She possesses extensive experience in quality issues associated with laboratory and material management, including controlled substances. Dr. Chang received a B.S. degree in Pharmacy from National Taiwan University in 1989 and a Ph.D. degree in Industrial and Physical Pharmacy from Purdue University in 1996.

Timeline

  • EVP, Quality Affairs

    Current role